You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Production of High Specific Activity Lutetium-177

    SBC: ALPHAMED, INC            Topic: N/A

    DESCRIPTION (provided by applicant): A separation method will be tested and evaluated to determine the feasibility of providing no carrier added lutetium-177 (Lu-177) for use in radiotherapeutic applications. An indirect method will be used to produce Lu-177 (neutron capture followed by decay). Separation of the Lu-177 from the target material will enable us to provide carrier-free Lu-177 suita ...

    STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  2. High-Energy Imaging in Support of Radionuclide Therapy

    SBC: ALPHAMED, INC            Topic: N/A

    DESCRIPTION (provided by applicant): The overall goal of this project is to design and build cameras that can efficiently detect and image isotopes that have gamma rays with energies that are typically beyond those effectively accessible with conventional cameras. There are no nuclear medicine clinical cameras, today, that combine high efficiency with the ability to image high-energy gamma rays. ...

    STTR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  3. Targeting alpha particle-emitting radionuclides to the nuclei of cancer cells

    SBC: ALPHAMED, INC            Topic: N/A

    DESCRIPTION (provided by applicant): This proposal outlines a body of research to evaluate the cytotoxicity and therapeutic efficacy of radiolabeled alpha-melanocyte stimulating hormone (a-MSH) peptide analogs that target a-particle emitting radioisotopes to the nuclei of melanoma cells. The selective targeting of alpha-particle emitting radioisotopes for cancer therapy is emerging as an exciting ...

    STTR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  4. Processing Ac-227 sources for lead-212 and radium-223 required by cancer research

    SBC: ALPHAMED, INC            Topic: N/A

    DESCRIPTION (provided by applicant): NIH sponsored cancer researchers have been obtaining promising results using molecules radiolabeled with lead-212 in treatment for metastatic melanoma and disseminated colon and pancreatic cancers. Another isotope, radium-223 is being used in clinical trials in treatment of skeletal metastases. There is no effective therapy for these diseases. Together 199,280 ...

    STTR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  5. A Pb-212 Generator Using Resistant Substrate and Rn Cold Trapping

    SBC: ALPHAMED, INC            Topic: N/A

    DESCRIPTION (provided by applicant): Targeted Pb-212 therapy in preclinical animal tests has shown a cure in groups receiving the highest dose of this therapy. Scaling the dose that was most efficacious in animal studies to people would bring the human dose required from 50 to 100 mCi. This application will research an approach that would provide a generator system that would support these require ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  6. Large N ASW False Alarm Reduction

    SBC: ALPHATECH, INC.            Topic: N/A

    The Large N ASW problem can be summarized as pervasive short-range sensors with limited communication capabilities. The driving questions are how are false alarms controlled-not necessarily from an individual sensor node, but from the overallfield-performance of individual sensor nodes, the amount of information and frequency of communication. From its inception, distributed detection has produc ...

    STTR Phase I 2003 Department of DefenseNavy
  7. Automated Synchronized Routing and Scheduling for Agile Aerial Platforms

    SBC: ALPHATECH, INC.            Topic: N04T003

    ALPHATECH proposes to develop a tool addressing the challenging problem of computing operationally realistic routes and activity schedules for aerial vehicles, accounting for the competing objectives and nonlinear constraints inherent in military path planning. Using an innovative combination of optimization techniques, this tool will generate platform trajectories and platform-task assignments a ...

    STTR Phase I 2004 Department of DefenseNavy
  8. T7 RNA polymerase engineering and RNA amplification

    SBC: AMBION DIAGNOSTICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Microarrays are powerful tools that can impact new diagnostic procedures and expedite the drug development process. A significant but largely unrealized application is gene expression analysis from RNAlimited samples, such as blood, needle biopsies, laser capture microdissection (LCM) samples, and even single cells. The most widely used T7 RNA polymerase-based ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  9. Single molecule fluorescence detection of fragile X mutations

    SBC: AMBION DIAGNOSTICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Fragile X Syndrome (FXS), is the most common form of inherited mental retardation, affecting 1 in 4000 males and about 1 in 6000 females of all ethnicities. Additionally, carrier frequencies are quite high. About 1 in 250 females carry Fragile X and about 1 in 800 men carry Fragile X. FXS was one of the first human diseases to be linked to an expansion of trip ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  10. Clean Gas Reformer- A Compact Fuel Reformer for Undersea Vehicle Fuel Cells

    SBC: ANALYTIC POWER LLC            Topic: N04T034

    Diesel fuel is a primary candidate for use aboard submarines. It has a high energy density and it is already in the Navy inventory. Fuel cells are attractive for submarines from an energy density perspective. Unfortunately, in hydrocarbon reforming power systems, the fuel cell power density is overshadowed by the fuel processing system which is often several times the size and cost of the fuel cel ...

    STTR Phase I 2004 Department of DefenseNavy
US Flag An Official Website of the United States Government